This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
ON Semiconductor (ON) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
ON Semiconductor's (ON) Q2 revenues are expected to have benefited from recovery in automotive and industrial sector.
FLEX Q1 Earnings and Revenues Surpass Estimates, Up Y/Y
by Zacks Equity Research
Flex (FLEX) Q1 results reflect continued strength in the Agility Solutions and Reliability Solutions segments.
Should You Buy Bruker (BRKR) Ahead of Earnings?
by Zacks Equity Research
Bruker (BRKR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Ultra Clean (UCTT) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Ultra Clean's (UCTT) Q2 results are likely to reflect solid demand for its semiconductor products and services, along with an expanding clientele.
MKS Instruments (MKSI) Q2 Earnings Top Estimates, Revenues Up
by Zacks Equity Research
MKS Instruments' (MKSI) Q2 results benefit from strength in the semiconductor market and recovery in advanced market revenues.
Cognizant's (CTSH) Q2 Earnings Beat, Revenues Increase Y/Y
by Zacks Equity Research
Cognizant's (CTSH) second-quarter 2021 results reflect robust performance across segments including Healthcare, Communications, Media and Technology.
Facebook's (FB) Q2 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
Facebook's (FB) second-quarter 2021 performance gains from robust ad revenues and user-base expansion in international markets.
Arista (ANET) to Report Q2 Earnings: Is a Beat in the Offing?
by Zacks Equity Research
Solid demand for cloud networking solutions, technological innovations and considerable top-line growth are likely to have aided Arista's (ANET) earnings in the second quarter of 2021.
Can Bruker (BRKR) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Bruker (BRKR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Amphenol (APH) Q2 Earnings Beat Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Amphenol's (APH) Q2 results reflect robust growth in the automotive, industrial, military and broadband end-markets.
Apple (AAPL) Q3 Earnings Beat, iPhone Strength Aids Top Line
by Zacks Equity Research
Apple's (AAPL) third-quarter fiscal 2021 results reflect robust performance of iPhone and Services segments.
MSCI Q2 Earnings and Revenues Beat Estimates, Shares Up
by Zacks Equity Research
MSCI's second-quarter 2021 results benefit from strong growth in recurring subscription revenues and asset-based fees.
Silicon Motion (SIMO) to Post Q2 Earnings: What to Expect?
by Zacks Equity Research
Silicon Motion's (SIMO) second-quarter results are likely to benefit from continued momentum in SSD controller sales, as well as healthy sales of eMMC and UFS controllers.
Bruker (BRKR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Bruker (BRKR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amphenol (APH) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Amphenol's (APH) second-quarter 2021 results are likely to reflect benefits from a diversified business model and accretive acquisitions.
3 Reasons Why Bruker (BRKR) Is a Great Growth Stock
by Zacks Equity Research
Bruker (BRKR) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Bruker (BRKR) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Bruker (BRKR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Bruker (BRKR) Updates 2021 Outlook, Issues Medium-Term View
by Zacks Equity Research
Bruker (BRKR) updates 2021 financial guidance encouraged by solid business growth and high-growth opportunities.
Bruker (BRKR) Hits a New 52-Week High: What's Driving It?
by Zacks Equity Research
Investors are optimistic about Bruker (BRKR) on solid CALID Group growth potential and raised 2021 financial guidance.
Bruker (BRKR) FluoroType Assay Detects New SARS-CoV-2 Variants
by Zacks Equity Research
Bruker's (BRKR) FluoroType SARS-CoV-2 varID Q assay differentiates and quantifies the SARS-CoV-2 virus in just one PCR test, thereby reducing workload, cost, and time.
Why Is Bruker (BRKR) Up 0.5% Since Last Earnings Report?
by Zacks Equity Research
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Industry Outlook Highlights: Mettler-Toledo International, PerkinElmer and Bruker Corp
by Zacks Equity Research
Zacks Industry Outlook Highlights: Mettler-Toledo International, PerkinElmer and Bruker Corp
Here's Why Momentum Investors Will Love Bruker (BRKR)
by Zacks Equity Research
Does Bruker (BRKR) have what it takes to be a top stock pick for momentum investors? Let's find out.
3 Stocks to Watch on Rising Demand for Scientific Instruments
by Aniruddha Ganguly
The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD), PerkinElmer (PKI) and Bruker Corporation (BRKR) are gaining from strong life science, pharmaceutical and academic end-market demand as well as rising healthcare spending.
3 Reasons Growth Investors Will Love Bruker (BRKR)
by Zacks Equity Research
Bruker (BRKR) could produce exceptional returns because of its solid growth attributes.